SB590885
10mM in DMSO
- Product Code: 233911
CAS:
405554-55-4
| Molecular Weight: | 453.54 g./mol | Molecular Formula: | C₂₇H₂₇N₅O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16038645 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
SB590885 is a potent and selective inhibitor of BRAF kinase, particularly effective against the BRAF V600E mutant form commonly found in melanoma and other cancers. Its primary application lies in cancer research, where it is used to study signaling pathways involving the MAPK/ERK cascade. By inhibiting aberrant BRAF activity, SB590885 helps researchers understand tumor cell proliferation, survival, and apoptosis mechanisms. It has been utilized in preclinical studies to evaluate the efficacy of BRAF-targeted therapies, especially in models of melanoma, colorectal cancer, and thyroid carcinoma. Due to its selectivity, it serves as a valuable tool for distinguishing BRAF-dependent effects from off-target actions in cellular and animal models. SB590885 is not used clinically but supports the development and validation of targeted cancer therapeutics.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | $283.65 |
+
-
|
SB590885
SB590885 is a potent and selective inhibitor of BRAF kinase, particularly effective against the BRAF V600E mutant form commonly found in melanoma and other cancers. Its primary application lies in cancer research, where it is used to study signaling pathways involving the MAPK/ERK cascade. By inhibiting aberrant BRAF activity, SB590885 helps researchers understand tumor cell proliferation, survival, and apoptosis mechanisms. It has been utilized in preclinical studies to evaluate the efficacy of BRAF-targeted therapies, especially in models of melanoma, colorectal cancer, and thyroid carcinoma. Due to its selectivity, it serves as a valuable tool for distinguishing BRAF-dependent effects from off-target actions in cellular and animal models. SB590885 is not used clinically but supports the development and validation of targeted cancer therapeutics.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :